RhoGTPases and Their Role in Cancer

Oncology Research

Volumn 13, Issue 6-10, 2002, Pages 323-331

  Li, Xiaoyu ^a   Lim, Bing ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Cancer and RhoGTPases; Gene expression and mutation; GTPase regulators and effectors; Inhibitory RhoGTPases

Indexed keywords

GUANINE NUCLEOTIDE BINDING PROTEIN; GUANINE NUCLEOTIDE DISSOCIATION INHIBITOR; GUANINE NUCLEOTIDE EXCHANGE FACTOR; GUANOSINE DIPHOSPHATE; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; PROTEIN CDC42; PROTEIN DERIVATIVE; RAC PROTEIN; RAS PROTEIN; RHO FACTOR; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; TUMOR SUPPRESSOR PROTEIN;

CANCER; CANCER INHIBITION; CELL CYCLE; CELL TRANSFORMATION; CONFERENCE PAPER; ENZYME ACTIVATION; ENZYME INHIBITION; GENE EXPRESSION; GENE MUTATION; HUMAN; MULTIGENE FAMILY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; NEOPLASM; PATHOPHYSIOLOGY; PHYSIOLOGY; RAT; REVIEW;

ANIMALS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASMS; RATS; RHO GTP-BINDING PROTEINS; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEINS;

EID: 0842305864     PISSN: 09650407     EISSN: None     Source Type: Journal    
DOI: 10.3727/096504003108748528     Document Type: Conference Paper

References (86)

1. Van Aelst, L.; D'Souza-Schorey, C. Rho GTPases and signaling networks. Genes Dev. 11:2295-2322; 1997.
2. Madaule, P.; Axel, R. A novel ras-related gene family. Cell 41:31-40; 1985.
3. Narumiya, S. The small GTPase Rho: Cellular functions and signal transduction. J. Biochem. 120:215-228; 1996.
4. Campbell, S. L.; Khosravi-Far, R.; Rossman, K. L.; Clark, G. J.; Der, C. J. Increasing complexity of Ras signaling. Oncogene 17:1395-1413; 1998.
5. Barbacid, M. ras genes. Annu. Rev. Biochem. 56:779-827; 1987.
6. Chardin, P.; Tavitian, A. The ral gene: A new ras related gene isolated by the use of a synthetic probe. EMBO J. 5:2203-2208; 1986.
7. Pizon, V.; Chardin, P.; Lerosey, I.; Olofsson, B.; Tavitian, A. Human cDNAs rap1 and rap2 homologous to the Drosophila gene Dras3 encode proteins closely related to ras in the 'effector' region. Oncogene 3:201-204; 1988.
8. Pfeffer, S. R. Rab GTPases: Master regulators of membrane trafficking. Curr. Opin. Cell. Biol. 6:522-526; 1994.
9. Touchot, N.; Chardin, P.; Tavitian, A. Four additional members of the ras gene superfamily isolated by an oligonucleotide strategy: Molecular cloning of YPT-related cDNAs from a rat brain library. Proc. Natl. Acad. Sci. USA 84:8210-8214; 1987.
10. Murphy, C.; Saffrich, R.; Parton, R. G.; Zerial, M. Endosome dynamics regulated by a Rho protein. Nature 384:427-432; 1996.
11. Foster, R.; Hu, K. G.; Thissen, J.; Settleman, J. Identification of a novel human Rho protein with unusual properties: GTPase deficiency and in vivo farnesylation. Mol. Cell. Biol. 16:2689-2699; 1996.
12. Vincent, S.; Jeanteur, P.; Fort, P. Growth-regulated expression of rhoG, a new member of the ras homolog gene family. Mol. Cell. Biol. 12:3138-3148; 1992.
13. Hall, A. Rho GTPases and the actin cytoskeleton. Nature 279:509-514; 1998.
14. Dallery, E.; Galiegue-Zouitina, S.; Collyn-d'Hooghe, M.; Quief, S.; Denis, C.; Hildebrand, M. P.; Lantoine, D.; Deweindt, C.; Tilly, H.; Bastard, C.; et al. TTF, a gene encoding a novel small G protein, fuses to the lymphoma-associated LAZ3 gene by t(3;4) chromosomal translocation. Oncogene 10:2171-2178; 1995.
15. Haataja, L.; Groffen, J.; Heisterkamp, N. Characterization of RAC3, a novel member of the Rho family. J. Biol. Chem. 272:20384-20388; 1997.
16. Drivas, G. T.; Shih, A.; Coutavas, E.; Rush, M. G.; D'Eu-stachio, P. Characterization of four novel ras-like genes expressed in a human teratocarcinoma cell line. Mol. Cell. Biol. 10:1793-1798; 1990.
17. Ridley, A. J.; Hall, A. The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors. Cell 70:389-399; 1992.
18. Ridley, A. J.; Paterson, H. F.; Johnston, C. L.; Diekmann, D.; Hall, A. The small GTP-binding protein rac regulates growth factor-induced membrane ruffling. Cell 70:401-410; 1992.
19. Nobes, C. D.; Hall, A. Rho, rac, and cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia. Cell 81:53-62; 1995.
20. Jaffe, A. B.; Hall, A. R. RhoGTPases in transformation and metastasis. Adv. Cancer Res. 84:57-80; 2002.
21. Boettner, B.; Van Aelst, L. The role of Rho GTPases in disease development. Gene 286:155-174; 2002.
22. Olson, M. F.; Ashworth, A.; Hall, A. An essential role for Rho, Rac, and Cdc42 GTPases in cell cycle progression through G1. Science 269:1270-1272; 1995.
23. Moore, K. A.; Sethi, R.; Finkel, T. Rac 1 is required for cell proliferation and G2/M progression. Biochem. J. 326:17-20; 1997.
24. Symons, M. The Rac and Rho pathways as a source of drug targets for Ras-mediated malignancies. Curr. Opin. Biotechnol. 6:668-674; 1995.
25. Qui, R-G.; Abo, A.; McCormick, F.; Symons, M. Cdc42 regulates anchorage-independent growth and is necessary for ras transformation. Mol. Cell. Biol. 17:3449-3458; 1997.
26. Avraham, H.; Weinberg, R. A. Characterization and expression of the human rhoH12 gene product. Mol. Cell. Biol. 9:2058-2066; 1989.
27. Cleverley, S. C.; Costello, P. S.; Henning, S. W.; Cantrell, D. A. Loss of Rho function in the thymus is accompanied by the development of thymic lymphoma. Oncogene 19:13-20; 2000.
28. Fritz, G.; Just, I.; Kaina, B. Rho GTPases are over-expressed in human tumors. Int. J. Cancer 81:682-687; 1999.
29. Fritz, G.; Brachetti, C.; Bahlmann, F.; Schmidt, M.; Kaina, B. Rho GTPases in human breast tumours: Expression and mutation analyses and correlation with clinical parameters. Br. J. Cancer 87:635-644; 2002.
30. Mira, J. P.; Benard, V.; Groffen, J.; Sanders, L. C.; Knaus, U. G. Endogenous, hyperactive Rac3 controls proliferation of breast cancer cells by a p21-activated kinase-dependent pathway. Proc. Natl. Acad. Sci. USA 97:185-189; 2000.
31. Clark, E. A.; Golub, T. R.; Lander, E. S.; Hynes, R. O. Genomic analysis of metastasis reveals an essential role for RhoC. Nature 406:532-535; 2000.
32. Kleer, C. G.; van Golen, K. L.; Zhang, Y.; Wu, Z. F.; Rubin, M. A.; Merajver, S. D. Characterization of RhoC expression in benign and malignant breast disease: A potential new marker for small breast carcinomas with metastatic ability. Am. J. Pathol. 160:579-584; 2002.
33. van Golen, K. L.; Bao, L. W.; Pan, Q.; Miller, F. R.; Wu, Z. F.; Merajver, S. D. Mitogen activated protein kinase pathway is involved in RhoC GTPase induced motility, invasion and angiogenesis in inflammatory breast cancer. Clin. Exp. Metastasis 19:301-311; 2002.
34. Crnogorac-Jurcevic, T.; Efthimiou, E.; Nielsen, T.; Loader, J.; Terris, B.; Stamp, G.; Baron, A.; Scarpa, A.; Lemoine, N. R. Expression profiling of microdissected pancreatic adenocarcinomas. Oncogene 21:4587-4594; 2002.
35. Forget, M. A.; Desrosiers, R. R.; Del, M.; Moumdjian, R.; Shedid, D.; Berthelet, F.; Beliveau, R. The expression of rho proteins decreases with human brain tumor progression: Potential tumor markers. Clin. Exp. Metastasis 19: 9-15; 2002.
36. Fritz, G.; Kaina, B. rhoB encoding a UV-inducible Ras-related small GTP-binding protein is regulated by GTPases of the Rho family and independent of JNK, ERK, and p38 MAP kinase. J. Biol. Chem. 272:30637-30644; 1997.
37. Liu, A. X.; Rane, N.; Liu, J. P.; Prendergast, G. C. RhoB is dispensable for mouse development, but it modifies susceptibility to tumor formation as well as cell adhesion and growth factor signaling in transformed cells. Mol. Cell. Biol. 21:6906-6912; 2001.
38. Pendergast, G. C. Actin' up: RhoB in cancer and apoptosis. Nat. Rev. Cancer 1:162-168; 2001.
39. Krzyzosiak, W. J.; Shindo-Okada, N.; Teshima, H.; Nakajima, K.; Nishimura, S. Isolation of genes specifically expressed in flat revertant cells derived from activated rastransformed NIH 3T3 cells by treatment with azatyrosine. Proc. Natl. Acad. Sci. USA 89:4879-4878; 1992.
40. Adnane, J.; Muro-Cacho, C.; Mathews, L.; Sebti, S. M.; Munoz-Antonia, T. Suppression of rho B expression in invasive carcinoma from head and neck cancer patients. Clin. Cancer Res. 8:2225-2232; 2002.
41. Tsubakimoto, K.; Matsumoto, K.; Abe, H.; Ishii, J.; Amano, M.; Kaibuchi, K.; Endo, T. Small GTPase RhoD suppresses cell migration and cytokinesis. Oncogene 18:2431-2440; 1999.
42. Hansen, S. H.; Zegers, M. M.; Woodrow, M.; Rodriguez-Viciana, P.; Chardin, P.; Mostov, K. E.; McMahon, M. Induced expression of Rnd3 is associated with transformation of polarized epithelial cells by the Raf-MEK-extracellular signal-regulated kinase pathway. Mol. Cell. Biol. 20:9364-9375; 2000.
43. Dallery-Prudhomme, E.; Roumier, C.; Kerckaert, J-P.; Galiegue-Zouitina, S. Genomic structure and assignment of the RhoH/TTF small GTPase gene (ARHH) to 4p13 by in situ hybridization. Genomics 43:89-94; 1997.
44. Preudhomme, C.; Roumier, C.; Hildebrand, M. P.; Dallery-Prudhomme, E.; Lantoine, D.; Lai, J. L.; Daudignon, A.; Adenis, C.; Bauters, F.; Fenaux, P.; Kerckaert, J. P.; Galiegue-Zouitina, S. Nonrandom 4p13 rearrangements of the RhoH/TTF gene, encoding a GTP-binding protein, in non-Hodgkin's lymphoma and multiple myeloma. Oncogene 19:2023-2032; 2000.
45. Pasqualucci, L.; Neumeister, P.; Goossens, T.; Nanjangud, G.; Chaganti, R. S.; Kuppers, R.; Dalla-Favera, R. Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas. Nature 412:341-346; 2001.
46. Shipp, M. A.; Ross, K. N.; Tamayo, P.; Weng, A. P.; Kutok, J. L.; Aguiar, R. C.; Gaasenbeek, M.; Angelo, M.; Reich, M.; Pinkus, G. S.; Ray, T. S.; Koval, M. A.; Last, K. W.; Norton, A.; Lister, T. A.; Mesirov, J.; Neuberg, D. S.; Lander, E. S.; Aster, J. C.; Golub, T. R. Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning. Nat. Med. 8:68-74; 2002,
47. Alizadeh, A. A.; Eisen, M. B.; Davis, R. E.; Ma, C.; Lossos, I. S.; Rosenwald, A.; Boldrick, J. C.; Sabet, H.; Tran, T.; Yu, X.; Powell, J. I.; Yang, L.; Marti, G.; Moore, T.; Hudson, J., Jr.; Lu, L.; Lewis, D. B.; Tibshirani, R.; Sherlock, G.; Chan, W. C.; Greiner, T. C.; Weisenbuger, D.; Armitage, J.; Warnke, R.; Staudt, L. M.; et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403:503-511; 2000.
48. Li, X.; Bu, X.; Lu, B.; Avraham, H.; Flavell, R. A.; Lim, B. The hematopoiesis-specific GTP-binding protein RhoH is GTPase deficient and modulates activities of other Rho GTPases by an inhibitory function. Mol. Cell. Biol. 22:1158-1171; 2002.
49. Boguski, M. S.; McCormick, F. Proteins regulating Ras and its relatives. Nature 366:643-654; 1993.
50. Katzav, S.; Martin-Zanca, D.; Barbacid, M. vav, a novel human oncogene derived from a locus ubiquitously expressed in hematopoietic cells. EMBO J. 8:2283-2290; 1989.
51. Toksoz, D.; Williams, D. A. Novel human oncogene lbc detected by transfection with distinct homology regions to signal transduction products. Oncogene 9:621-628; 1994.
52. Cerione, R.; Zheng, Y. The Dbl family of oncogenes. Curr. Opin. Cell. Biol. 8:216-222; 1996.
53. Habets, G. G.; Scholtes, E. H.; Zuydgeest, D.; van der Kammen, R. A.; Stam, J. C.; Berns, A.; Collard, J. G. Identification of an invasion-inducing gene, Tiam-1, that encodes a protein with homology to GDP-GTP exchangers for Rho-like proteins. Cell 77:537-549; 1994.
54. Engers, R.; Zwaka, T. P.; Gohr, L.; Weber, A.; Gerharz, C.; Gabbert, H. E. Tiam1 mutations in human renal-cell carcinomas. Int. J. Cancer 88:369-376; 2000.
55. Malliri, A.; van der Kammen, R. A.; Clark, K.; van der Valk, M.; Michiels, F.; Collard, J. G. Mice deficient in the Rac activator Tiam1 are resistant to Ras-induced skin tumours. Nature 417:867-871; 2002.
56. Reuther, G. W.; Lambert, Q. T.; Booden, M. A.; Wennerberg, K.; Becknell, B.; Marcucci, G.; Sondek, J.; Caligiuri, M. A.; Der, C. J. Leukemia-associated Rho guanine nucleotide exchange factor, a Dbl family protein found mutated in leukemia, causes transformation by activation of RhoA. J. Biol. Chem. 276:27145-27151; 2001.
57. Ueda, T.; Kikuchi, A.; Ohga, N.; Yamamoto, J.; Takai, Y. Purification and characterization from bovine brain cytosol of a novel regulatory protein inhibiting the dissociation of GDP from and the subsequent binding of GTP to rhoB p20, a ras p21-like GTP-binding protein. J. Biol. Chem. 265:9373-9380; 1990.
58. Lelias, J. M.; Adra, C.; Wulf, G. M.; Guillemot, J. C.; Khagad, M.; Caput, D.; Lim, B. cDNA cloning of a human mRNA preferentially expressed in hematopoietic cells and with homology to a GDP-dissociation inhibitor for the rho GTP-binding proteins. Proc. Natl. Acad. Sci. USA 90:1479-1483; 1993.
59. Adra, C. N.; Manor, D.; Cerione, R.; Lim, B. RhoGDIγ. A GDP-dissociation inhibitor for Rho proteins with preferential expression in brain and pancreas. Proc. Natl. Acad. Sci. USA 94:4279-4284; 1997.
60. Takahashi, K.; Sasaki, T.; Kameyama, T.; Tsukita, S.; Takai, Y. Translocation of activated Rho from the cytoplasm to membrane ruffling area, cell-cell adhesion sites and cleavage furrows. Oncogene 11:39-48; 1995.
61. Togawa, A.; Miyoshi, J.; Ishizaki, H.; Tanaka, M.; Takakura, A.; Nishioka, H.; Yoshida, H.; Doi, T.; Mizoguchi, A.; Matsuura, N.; Niho, Y.; Nishimune, Y.; Nishikawa, S.; Takai, Y. Progressive impairment of kidneys and reproductive organs in mice lacking Rho GDIalpha. Oncogene 18:5373-5380; 1999.
62. Jones, M. B.; Krutzsch, H.; Shu, H.; Zhao, Y.; Liotta, L. A.; Kohn, E. C.; Petricoin, E. F., 3rd. Proteomic analysis and identification of new biomarkers and therapeutic targets for invasive ovarian cancer. Proteomics 2:76-84; 2002.
63. Lesley, J.; Hyman, R.; Kincade, P. W. CD44 and its interaction with extracellular matrix. Adv. Immunol. 54:271-335; 1993.
64. Stamenkovic, I.; Amiot, M.; Pesando, J. M.; Seed, B. A lymphocyte molecule implicated in lymph node homing is a member of the cartilage link protein family. Cell 56:1057-1062; 1989.
65. Gao, A. C.; Lou, W.; Dong, J. T.; Isaacs, J. T. CD44 is a metastasis suppressor gene for prostatic cancer located on human chromosome 11p13. Cancer Res. 57:846-849; 1997.
66. Kallakury, B. V.; Yang, F.; Figge, J.; Smith, K. E.; Kausik, S. J.; Tacy, N. J.; Fisher, H. A.; Kaufman, R.; Figge, H.; Ross, J. S. Decreased levels of CD44 protein and mRNA in prostate carcinoma. Correlation with tumor grade and ploidy. Cancer 78:1461-1469; 1996.
67. Woodman, A. C.; Sugiyama, M.; Yoshida, K.; Sugino, T.; Borgya, A.; Goodison, S.; Matsumura, Y.; Tarin, D. Analysis of anomalous CD44 gene expression in human breast, bladder, and colon cancer and correlation of observed mRNA and protein isoforms. Am. J. Pathol. 149:1519-1530; 1996.
68. Tsukita, S.; Yonemura, S. Corttical actin organization: Lessons from ERM (ezrin/radixin/moesin) proteins. J. Biol. Chem. 274:34507-34510; 1999.
69. Tsukita, S.; Yonemura, S. ERM (enrin/radixin/moesin) family from cytoskeleton to signal transduction. Curr. Opin. Cell. Biol. 9:70-75; 1997.
70. Amieva, M. R.; Furthmayr, H. Subcellular localization of moesin in dynamic filopodia, retraction fibers, and other structures involved in substrate exploration, attachment, and cell-cell contacts. Exp. Cell. Res. 219:180-196; 1995.
71. Hirao, M.; Sato, N.; Kondo, T.; Yonemura, S.; Monden, M.; Sasaki, T.; Takai, Y.; Tsukita, S.; Tsukita, S. Regulation mechanism of ERM (ezrin/radixin/moesin) protein/ plasma membrane association: Possible involvement of phosphatidylinositol turnover and Rho-dependent signaling pathway. J. Cell Biol. 135:37-51; 1996.
72. Kotani, H.; Takahashi, K.; Sasaki, T.; Takai, Y. Rho regulates association of both the ERM family and vinculin with the plasma membrane in MDCK cells. Oncogene 14:1705-1713; 1997.
73. Tran Quang, C.; Gautreau, A.; Arpin, M.; Treisman, R. Ezrin function is required for ROCK-mediated fibroblast transformation by the Net and Dbl oncogenes. EMBO J. 19:4565-4576; 2000.
74. Cichowski, K.; Jacks, T. NF1 tumor suppressor gene function: Narrowing the GAP. Cell 104:593-604; 2001.
75. Pei, L.; Peng, Y.; Yang, Y.; Ling, X. B.; Van Eyndhoven, W. G.; Nguyen, K. C.; Rubin, M.; Hoey, T.; Powers, S.; Li, J. PRC17, a novel oncogene encoding a Rab GTPase-activating protein, is amplified in prostate cancer. Cancer Res. 62:5420-5424; 2002.
76. Hill, C. S.; Wynne, J.; Treisman, R. The Rho family GTPases RhoA, Rac, and CDC42Hs regulate transcriptional activation by SRF. Cell 81:1159-1170; 1995.
77. Minden, A.; Lin, A.; Claret, F. X.; Abo, A.; Karin, M. Selective activation of the JNK signaling cascade and c-Jun transcriptional activity by the small GTPases Rac and Cdc42Hs. Cell 81:1147-1157; 1995.
78. Teramoto, H.; Crespo, P.; Xu, N.; Gutkind, J. S. The small GTP-binding protein rho activates c-Jun N-terminal kinases/stress-activated protein kinases in human kidney 293T cells. Evidence for a Pak-independent signaling pathway. J. Biol. Chem. 271:25731-25734; 1996.
79. Perona, R.; Montaner, S.; Bravo, R.; Lacal, J. C. Activation of the nuclear factor-κB by Rho, DCD42, and Rac-1 proteins. Genes Dev. 11:463-475; 1997.
80. Bishop, A. L.; Hall, A. Rho GTPases and their effector proteins. Biochem. J. 348:241-255; 2000.
81. Manser, E.; Leung, T.; Salihuddin, H.; Zhao, Z. Z.; Lim, L. A brain serine/threonine protein kinase activated by Cdc42 and Rac1. Nature 367:40-46; 1994.
82. Tang, Y.; Chen, Z.; Ambrose, D.; Liu, J.; Gibbs, J. B.; Chernoff, J.; Field, J. Kinase deficient Pak1 mutants inhibit Ras transformation of Tat 1 fibroblasts. Mol. Cell. Biol. 17:4454-4464; 1997.
83. Adam, L.; Vadlamudi, R.; Mandal, M.; Chernoff, J.; Kumar, R. Regulation of microfilament reorganization and invasiveness of breast cancer cells by kinase dead p21-activated kinase1. J. Biol. Chem. 275:12041-12050; 2000.
84. Itoh, K.; Yoshioka, K.; Akedo, H.; Uehata, M.; Ishizaki, T.; Narumiya, S. An essential part for Rho-associated kinase in the transcellular invasion of tumor cells. Nat. Med. 5:221-225; 1999.
85. Somlyo, A. V.; Bradshaw, D.; Ramos, S.; Murphy, C.; Myers, C. E.; Somlyo, A. P. Rho-kinase inhibitor retards migration and in vivo dissemination of human prostate cancer cells. Biochem. Biophys. Res. Commun. 269:652-659; 2000.
86. Takamura, M.; Sakamato, M.; Genda, T.; Ichida, T.; Asakura, H.; Hirohashi, S. Inhibition of intrahepatic metastasis of human hepatocellular carcinoma by Rho-associated kinase inhibitor. Hepatology 33:577-581; 2001.